The rapid integration of artificial intelligence (AI) and machine learning (ML) tools into clinical diagnostics is transforming healthcare delivery, offering unprecedented potential for improving diagnostic accuracy, efficiency, and early disease detection. From radiology and pathology to genomics and predictive analytics, AI systems are increasingly used to assist clinicians in complex decision-making processes. However, the growing reliance on these technologies raises significant legal and regulatory challenges that must be addressed to ensure patient safety, fairness, and accountability. This examines the evolving legal landscape surrounding the regulation of AI-powered diagnostic tools in clinical settings. It explores key regulatory frameworks, such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the International Medical Device Regulators Forum (IMDRF), which govern the approval, monitoring, and oversight of AI-based medical devices. Special attention is given to the unique challenges posed by adaptive, continuously learning algorithms that evolve beyond their original regulatory approval. The analysis further delves into ethical and legal issues related to algorithmic transparency, accountability for diagnostic errors, data privacy, and algorithmic bias, particularly in vulnerable patient populations. Questions concerning liability for AI-assisted clinical decisions, professional responsibility, and the adequacy of informed consent in AI-supported diagnostics are also addressed. In light of these complexities, this proposes policy recommendations emphasizing the need for robust, adaptive regulatory frameworks, cross-sector collaboration, and the development of clear standards for clinical validation, algorithmic explainability, and human oversight. This argues for a balanced approach that fosters innovation while safeguarding patient rights and promoting equitable access to trustworthy AI diagnostics. Ultimately, regulating AI in clinical decision-making is critical for maintaining public trust, ensuring legal accountability, and advancing ethical, safe, and effective integration of AI technologies into healthcare systems worldwide.
Akomolafe et al. (Wed,) studied this question.